Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 825 of 984 entries
View as:

A Study of Real Life Treatment for Multiple Myeloma (MM)

Phase: N/A Priority: Normal
NCT ID: NCT04985643 Org: User:
Start: 02/18/22 End: 08/30/25 Due: 08/30/26

A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03589326 Org: User:
Start: 10/04/18 End: 07/31/27 Due: 07/31/28

A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)

Phase: N/A Priority: Normal
NCT ID: NCT06579755 Org: User:
Start: 04/01/26 End: 04/14/27 Due: 04/14/28

A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in Argentina

Phase: N/A Priority: Normal
NCT ID: NCT04955964 Org: User:
Start: 07/28/21 End: 08/07/23 Due: 08/07/24

A Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velaglucerase Alfa (VPRIV) Home Infusion

Phase: N/A Priority: Normal
NCT ID: NCT05669729 Org: User:
Start: 09/30/26 End: 09/30/27 Due: 09/30/28

A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty

Phase: N/A Priority: Normal
NCT ID: NCT05341115 Org: User:
Start: 03/14/23 End: 03/10/25 Due: 03/10/26

A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT04873700 Org: User:
Start: 08/30/21 End: 05/17/22 Due: 05/17/23

A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release Capsules

Phase: N/A Priority: Normal
NCT ID: NCT03801148 Org: User:
Start: 01/10/19 End: 04/09/19 Due: 04/09/20

Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT02611817 Org: User:
Start: 01/04/16 End: 08/06/19 Due: 08/06/20

A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real Life

Phase: N/A Priority: Normal
NCT ID: NCT03378388 Org: User:
Start: 02/13/18 End: 02/15/19 Due: 02/15/20

Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00286455 Org: User:
Start: 02/28/06 End: 07/31/07 Due: 07/31/08

A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia

Phase: N/A Priority: Normal
NCT ID: NCT06388785 Org: User:
Start: 09/26/24 End: 05/08/27 Due: 05/08/28

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

Phase: N/A Priority: Normal
NCT ID: NCT03999996 Org: User:
Start: 11/12/19 End: 05/25/24 Due: 05/25/25

Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.

Phase: N/A Priority: Normal
NCT ID: NCT03234907 Org: User:
Start: 08/03/17 End: 08/14/20 Due: 08/14/21

A Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy Alone

Phase: N/A Priority: Normal
NCT ID: NCT06104878 Org: User:
Start: 12/31/23 End: 10/31/24 Due: 10/31/25

Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00591266 Org: User:
Start: 10/31/07 End: 04/30/09 Due: 04/30/10

Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00770497 Org: User:
Start: 03/31/07 End: 05/31/08 Due: 05/31/09

Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants

Phase: N/A Priority: Normal
NCT ID: NCT02367885 Org: User:
Start: 02/28/15 End: 05/31/15 Due: 05/31/16

Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"

Phase: N/A Priority: Normal
NCT ID: NCT03729609 Org: User:
Start: 11/01/18 End: 09/27/23 Due: 09/27/24

A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01568398 Org: User:
Start: 05/31/12 End: 08/31/13 Due: 08/31/14

A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06793943 Org: User:
Start: 01/23/25 End: 03/30/25 Due: 03/30/26

Effects of Vortioxetine (Lu AA21004) on the Concentrations of Selected Neurotransmitters in Healthy Male Adults

Phase: N/A Priority: Normal
NCT ID: NCT01299805 Org: User:
Start: 03/31/11 End: 07/31/11 Due: 07/31/12

A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula

Phase: N/A Priority: Normal
NCT ID: NCT04118088 Org: User:
Start: 12/22/20 End: 02/14/25 Due: 02/14/26

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Phase: N/A Priority: Normal
NCT ID: NCT00251758 Org: User:
Start: 12/31/05 End: 05/31/06 Due: 05/31/07

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT00251719 Org: User:
Start: 12/31/05 End: 01/31/07 Due: 01/31/08